Patents Assigned to Molecular Staging Inc.
  • Publication number: 20050196817
    Abstract: Biomarkers for sepsis and resulting mortality can be detected by assaying blood samples. Changes in the concentration of the biomarkers can be used to indicate sepsis, risk of sepsis, progression of sepsis, remission from sepsis, and risk of mortality. Changes can be evaluated relative to data sets, natural or synthetic or semisynthetic control samples, or patient samples collected at different time points. Some biomarkers' concentrations are elevated during disease and some are depressed. These are termed informative biomarkers. Some biomarkers are diagnostic in combination with others. Individual biomarkers may be weighted when used in combinations. Biomarkers can be assessed in individual, isolated or assays, in parallel assays, or in single-pot assays.
    Type: Application
    Filed: January 20, 2004
    Publication date: September 8, 2005
    Applicant: Molecular Staging Inc.
    Inventors: Stephen Kingsmore, Serguei Lejnine, Mark Driscoll, Velizar Tchernev
  • Patent number: 6830884
    Abstract: The present invention relates generally to a method of amplifying closed circular nucleic acid probes and, more particularly, to a method of amplifying closed circular nucleic acid probes by rolling circle amplification. The method of the present invention is useful in a range of applications involving the detection of nucleic acid sequences such as, but not limited to, the identification of genetic disorders, genetic variants or the presence of microbiological or viral agents.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: December 14, 2004
    Assignee: Molecular Staging Inc.
    Inventors: Gregory John Hafner, Philip Morrison Giffard, Lindsay Colin Wolter, James Langham Dale, Mark Richard Stafford, Ilin Chen Hai-Ni Yang, Joanne Voisey
  • Patent number: 6811986
    Abstract: The present invention provides a novel method for ligation of oligonucleotides containing 5′-phosphorothioates on complementary templates by the action of DNA ligases. This reaction is readily applied to the synthesis of a single stranded circular DNA containing a phosphorothioate linkage at the site of ligation junction. The efficiency of 5′-phosphorothioate directed ligation reaction by ATP dependent DNA ligase reaction is similar to conventional 5′-phosphate ligation. The utility of enzymatic ligation in probing specific sequences of DNA is also described. The present invention also provides a novel non-enzymatic ligation of 5′-phosphorothioates that has been applied to the synthesis of single strand phosphorothioate and phosphate circular DNA.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: November 2, 2004
    Assignee: Molecular Staging, Inc.
    Inventors: Rajanikanth Bandaru, Gyanendra Kumar
  • Patent number: 6777183
    Abstract: Disclosed are methods for allele discrimination involving the use of rolling circle amplification (RCA) coupled with primer extension and utilizing exonuclease deficient polymerases to distinguish matched and unmated single nucleotide sites, such as in the case of a single nucleotide polymorphism (SNP).
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: August 17, 2004
    Assignee: Molecular Staging, Inc.
    Inventor: Patricio AbarzĂșa
  • Publication number: 20040101510
    Abstract: We measured the levels of 78 different cytokines and growth factors in culture supernatants to determine the cytokine profiles of cells treated with PARC. We found that specific cytokines were suppressed by PARC. PARC can be used to treat diseases such as cancer, autoimmune diseases, rheumatoid arthritis, myeloproliferative disorders, and coronary artery disease, which are characterized by too much mitosis.
    Type: Application
    Filed: September 12, 2003
    Publication date: May 27, 2004
    Applicant: Molecular Staging Inc.
    Inventors: Qin Fu, Velizar T. Tchernev, Ebenezer Satyaraj, Dhavalkumar D. Patel, Stephen F. Kingsmore
  • Patent number: 6686157
    Abstract: Disclosed is a method and compositions for the sensitive detection of the amount and location of specific nucleic acid sequences. The method makes use of a branched oligomer, referred to as a lollipop oligomer, that has a tail portion, a right arm portion, and a left arm portion. These three components are joined at a common junction making a three-tailed structure. The two arms each end with sequences complementary to adjacent sequences in a target sequence. This allows the right and left arms to be ligated together when the oligomer is hybridized to the target sequence, thus topologically linking the oligomer to the target sequence. The tail portion can then be detected at the location of the target sequence.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: February 3, 2004
    Assignee: Molecular Staging Inc.
    Inventors: David C. Ward, Patricia Bray-Ward, Michael J. Lane, Gyanendra Kumar
  • Publication number: 20040009503
    Abstract: Human extracellular ribonucleases (RNases) are widely distributed in various organs and body fluids and together with other members of the mammalian RNase A superfamily. In addition to their RNase activity, several RNases have been shown to have special biological actions, i.e., antitumor, antiviral and angiogenic properties. However, the molecular mechanisms of such activities are unclear. Using protein microarrays amplified rolling circle amplification (RCA), we investigated the effects of EDN (Rnase 2), ECP (Rnase 3) and RNase 1 on leukocytes cytokine production. We measured the levels of 78 different cytokines and growth factors in culture supernatants to determine the cytokine profiles of cells treated with different combinations of RNases and RNase inhibitors.
    Type: Application
    Filed: March 26, 2003
    Publication date: January 15, 2004
    Applicant: Molecular Staging, Inc.
    Inventors: Qin Fu, Velizar Tchernev, Ebenezer Satyaraj, Dhavalkumar D. Patel, Stephen F. Kingsmore, Barry Schweitzer
  • Patent number: 6670126
    Abstract: Methods for the amplification of selected nucleic acids at high rate but with high specificity and control are disclosed using a secondary, tertiary, quaternary or higher order platform especially designed to amplify selected sequences within the primary product of linear or exponential rolling circle amplification and amplifying said sequences along with specialized detector or reporter molecules that serve to enhance the ability to detect the amplification products.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: December 30, 2003
    Assignee: Molecular Staging, Inc.
    Inventors: Stephen Kingsmore, R. Steven Wiltshire, Jeremy P. Lambert
  • Patent number: 6635425
    Abstract: The present invention provides a novel method for ligation of oligonucleotides containing 5′-phosphorothioates on complementary templates by the action of DNA ligases. This reaction is readily applied to the synthesis of a single stranded circular DNA containing a phosphorothioate linkage at the site of ligation junction. The efficiency of 5′-phosphorothioate directed ligation reaction by ATP dependent DNA ligase reaction is similar to conventional 5′-phosphate ligation. The utility of enzymatic ligation in probing specific sequences of DNA is also described. The present invention also provides a novel non-enzymatic ligation of 5′-phosphorothioates that has been applied to the synthesis of single strand phosphorothioate and phosphate circular DNA.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: October 21, 2003
    Assignee: Molecular Staging, Inc.
    Inventors: Rajanikanth Bandaru, Gyanendra Kumar
  • Patent number: 6617137
    Abstract: Disclosed are compositions and a method for amplification of nucleic acid sequences of interest. The disclosed method generally involves replication of a target sequence such that, during replication, the replicated strands are displaced from the target sequence by strand displacement replication of another replicated strand. In one form of the disclosed method, the target sample is not subjected to denaturing conditions. It was discovered that the target nucleic acids, genomic DNA, for example, need not be denatured for efficient multiple displacement amplification. The primers used can be hexamer primers. The primers can also each contain at least one modified nucleotide such that the primers are nuclease resistant. The primers can also each contain at least one modified nucleotide such that the melting temperature of the primer is altered relative to a primer of the same sequence without the modified nucleotide(s). The DNA polymerase can be &phgr;29 DNA polymerase.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: September 9, 2003
    Assignee: Molecular Staging Inc.
    Inventors: Frank B. Dean, Roger S. Lasken
  • Publication number: 20030143587
    Abstract: Disclosed are compositions and a method for amplification of nucleic acid sequences of interest. The disclosed method generally involves replication of a target sequence such that, during replication, the replicated strands are displaced from the target sequence by strand displacement replication of another replicated strand. In one form of the disclosed method, the target sample is not subjected to denaturing conditions. It was discovered that the target nucleic acids, genomic DNA, for example, need not be denatured for efficient multiple displacement amplification. The primers used can be hexamer primers. The primers can also each contain at least one modified nucleotide such that the primers are nuclease resistant. The primers can also each contain at least one modified nucleotide such that the melting temperature of the primer is altered relative to a primer of the same sequence without the modified nucleotide(s). The DNA polymerase can be &phgr;29 DNA polymerase.
    Type: Application
    Filed: October 15, 2002
    Publication date: July 31, 2003
    Applicant: Molecular Staging, Inc.
    Inventors: Frank B. Dean, Roger S. Lasken, Linhua Fang, A. Fawad Faruqi, Osama A. Alsmadi, Mark D. Driscoll, Seiyu Hosono, Michele Wisniewski, Wanmin Song
  • Patent number: 6576448
    Abstract: DNA containing nucleotide base mispairs can be isolated using a modified rolling circle amplification procedure. Specific Y-shaped adapters permit the selective circularization of these fragments with a complementary splint oligonucleotide. Rolling circle amplification is then carried out with a DNA polymerase. Rolling circle amplification can also be carried out using a mixture of DNA circles having different lengths. Genetic phase of linked DNA markers can be determined by selective amplification of one parental haplotype. DNA fragments can also be converted into a form that can be utilized as rolling circle amplification templates by ligation of hairpin forming adapters to the ends of the fragments. Two or more DNA polymerases can be used in a rolling circle amplification reaction. DNA polymerase III has special properties that improve rolling circle amplification.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: June 10, 2003
    Assignees: Molecular Staging, Inc., Yale University
    Inventors: Sherman Weissman, Roger Lasken
  • Patent number: 6573051
    Abstract: Disclosed are compositions and methods for reducing or eliminating generation of unwanted, undesirable, or non-specific amplification products in nucleic acid amplification reactions, such as rolling circle amplification. One form of composition is an open circle probe that can form an intramolecular stem structure, such as a hairpin structure, at one or both ends. The stem structure allows the open circle probe to be circularized when hybridized to a legitimate target sequence but results in inactivation of uncircularized open circle probes. This inactivation, which preferably involves stabilization of the stem structure, extension of the end of the open circle probe, or both, reduces or eliminates the ability of the open circle probe to prime nucleic acid synthesis or to serve as a template for rolling circle amplification. The disclosed method is useful for detection, quantitation, and/or location of any desired analyte, such as proteins and peptides.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: June 3, 2003
    Assignee: Molecular Staging, Inc.
    Inventors: Osama A. Alsmadi, Patricio Abarzua
  • Patent number: 6531283
    Abstract: Disclosed are compositions and methods for detecting small quantities of analytes such as proteins and peptides. The method involves associating a primer with an analyte and subsequently using the primer to mediate rolling circle replication of a circular DNA molecule. Amplification of the DNA circle is dependent on the presence of the primer. Thus, the disclosed method produces an amplified signal, via rolling circle amplification, from any analyte of interest. The amplified DNA remains associated with the analyte, via the primer, and so allows spatial detection of the analyte. The disclosed method can be used to detect and analyze proteins and peptides. Multiple proteins can be analyzed using microarrays to which the various proteins are immobilized. A rolling circle replication primer is then associated with the various proteins using a conjugate of the primer and a molecule that specifically binds the proteins to be detectable.
    Type: Grant
    Filed: June 20, 2000
    Date of Patent: March 11, 2003
    Assignee: Molecular Staging, Inc.
    Inventors: Stephen Kingsmore, Girish Nallur, Barry Schweitzer
  • Patent number: 6498023
    Abstract: The present invention provides a method for the rapid simultaneous production of a plurality of single-stranded DNA circles having a predetermined size and nucleotide sequence using pre-designed hairpin oligonucleotides containing complementary sequences for directing ligation to form dumbbell-shaped monomers followed by heat denaturation to yield single-stranded DNA circles.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: December 24, 2002
    Assignee: Molecular Staging, Inc.
    Inventor: Patricio AbarzĂșa
  • Patent number: 6372434
    Abstract: Genomic or cDNA, or fragments and mixtures thereof, can be screened by generation of subsets and then subjecting the subsets to mismatch scanning procedures. Alternatively, DNA fragments can be generated by cutting with a restriction endonuclease that generates variable overhangs. For either of the above methods, Y-shaped adapters having a region of non-complementary single-stranded DNA at the end can be used. Heterohybrid DNA, containing one DNA strand derived from each of two different samples, or homohybrids, containing DNA strands from the same sample, can be selected. Adapters attached to the ends of the fragments are designed to allow the selective isolation of homohybrid or heterohybrid DNA.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: April 16, 2002
    Assignee: Molecular Staging, Inc.
    Inventors: Sherman Weissman, Roger Lasken, Xinghua Pan
  • Patent number: 6368801
    Abstract: Disclosed are techniques for detection of nucleic acids, amplification of nucleic acids, or both, involving ligation by T4 RNA ligase of DNA strands hybridized to an RNA strand. These techniques are particularly useful for the detection of RNA sequences and for amplification of nucleic acids from, or dependent on, RNA sequences. It has been discovered that T4 RNA ligase can efficiently ligate DNA ends of nucleic acid strands hybridized to an RNA strand. In particular, this ligation is more efficient than the same ligation carried out with T4 DNA ligase. Thus, techniques involving ligation of DNA ends of nucleic acid strands hybridized to RNA can be performed more efficiently by using T4 RNA ligase. Many known ligation-based detection and amplification techniques are improved through the use of T4 RNA ligase acting on DNA strands or ends.
    Type: Grant
    Filed: April 12, 2000
    Date of Patent: April 9, 2002
    Assignee: Molecular Staging, Inc.
    Inventor: A. Fawad Faruqi
  • Patent number: 6346399
    Abstract: Genomic or cDNA, or fragments and mixtures thereof, can be screened by generation of subsets and then subjecting the subsets to mismatch scanning procedures. Alternatively, DNA fragments can be generated by cutting with a restriction endonuclease that generates variable overhangs. For either of the above methods, Y-shaped adapters having a region of non-complementary single-stranded DNA at the end can be used. Heterohybrid DNA, containing one DNA strand derived from each of two different samples, or homohybrids, containing DNA strands from the same sample, can be selected. Adapters attached to the ends of the fragments are designed to allow the selective isolation of homohybrid or heterohybrid DNA.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: February 12, 2002
    Assignees: Yale University, Molecular Staging, Inc.
    Inventors: Sherman Weissman, Roger Lasken, Xinghua Pan
  • Patent number: 6323009
    Abstract: Processes for the amplification of target DNA sequences in the form of single or double stranded circular DNA molecules, especially those present in colony and plaque extracts, using multiple specific and/or random sequence oligonucleotide primers are disclosed along with methods for detecting such amplified target sequences. A kit containing components for use in the invention is also described.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: November 27, 2001
    Assignee: Molecular Staging, Inc.
    Inventors: Roger S. Lasken, Frank B. Dean, John Nelson
  • Patent number: 6291187
    Abstract: Methods for the amplification of selected nucleic acids at high rate but with high specificity and control are disclosed using a secondary, tertiary, quaternary or higher order platform especially designed to amplify selected sequences within the primary product of linear or exponential rolling circle amplification and amplifying said sequences along with specialized detector or reporter molecules that serve to enhance the ability to detect the amplification products.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: September 18, 2001
    Assignee: Molecular Staging, Inc.
    Inventors: Stephen Kingsmore, R. Steven Wiltshire, Jeremy P. Lambert